Key result
Atrial fibrillation affects up to 27% of long-term hemodialysis patients, and two-year death rates for chronic kidney disease patients after stroke range between 55% and 74%.
Population
Patients with chronic kidney disease (CKD) and atrial fibrillation (AF)
Design
Review
Authors
Loading...
High AF burden and post-stroke mortality in CKD patients demand heightened clinical vigilance; leaves open optimal anticoagulation strategies in advanced disease.
This review highlights the high prevalence of AF and stroke risk in CKD patients and discusses oral anticoagulation strategies, including DOACs, for this undertreated population.
Engelbertz et al. (2012) conducted a review in Atrial Fibrillation and Chronic Kidney Disease. Oral anticoagulation was evaluated. Atrial fibrillation affects up to 27% of long-term hemodialysis patients, and two-year death rates for chronic kidney disease patients after stroke range between 55% and 74%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: